Your browser doesn't support javascript.
loading
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
Alexander, Jason T; Staab, Erin M; Wan, Wen; Franco, Melissa; Knitter, Alexandra; Skandari, M Reza; Bolen, Shari; Maruthur, Nisa M; Huang, Elbert S; Philipson, Louis H; Winn, Aaron N; Thomas, Celeste C; Zeytinoglu, Meltem; Press, Valerie G; Tung, Elizabeth L; Gunter, Kathryn; Bindon, Brittany; Jumani, Sanjay; Laiteerapong, Neda.
Afiliação
  • Alexander JT; Department of Medicine, University of Chicago, Chicago, IL, USA. jalexander3@medicine.bsd.uchicago.edu.
  • Staab EM; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Wan W; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Franco M; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Knitter A; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Skandari MR; Centre for Health Economics and Policy Innovation, Imperial College Business School, London, UK.
  • Bolen S; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Maruthur NM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Huang ES; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Philipson LH; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Winn AN; Department of Clinical Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Thomas CC; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Zeytinoglu M; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Press VG; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Tung EL; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Gunter K; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Bindon B; Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Jumani S; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Laiteerapong N; Department of Medicine, University of Chicago, Chicago, IL, USA.
J Gen Intern Med ; 37(2): 415-438, 2022 02.
Article em En | MEDLINE | ID: mdl-34508290

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Gen Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Gen Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos